Clinical trial
Long-Term Evaluation of the Performance and Safety of the IntraSPINE® Interlaminar Implant in the Treatment of Lumbar Degenerative Disc Disease
NCT07790328 is registered in ClinicalTrials.gov with Cousin Biotech as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Evaluation of the Performance and Safety of the IntraSPINE® Interlaminar Implant in the Treatment of Lumbar Degenerative Disc Disease
- Lead sponsor
- Cousin Biotech
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 28, 2020
- Completion date
- June 1, 2031
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
joint facet syndrome, lower back pain of disc origin, lumbar canal stenosis, spinal disease